AVITA Medical (RCEL) Work In Process (2021 - 2022)
AVITA Medical (RCEL) posted Work In Process of $384000.0 for Q4 2022, up 118.18% on a QoQ basis from $176000.0 in Q4 2021, and up 118.18% year-over-year from $176000.0 in Q4 2021.
AVITA Medical (RCEL) Work In Process (2021 - 2022) Analysis & Trends
AVITA Medical's Work In Process history runs 2 years deep, the most recent figure standing at $384000.0 for Q4 2022.
- Quarterly Work In Process rose 118.18% year-over-year to $384000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $384000.0 (up 118.18% YoY) and the FY2022 annual result came in at $384000.0, up 118.18% from the prior year.
- Work In Process was $384000.0 for Q4 2022 at AVITA Medical, up from $176000.0 in the prior quarter.
- Across five years, Work In Process topped out at $384000.0 in Q4 2022 and bottomed at $176000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 384,000.00 |
| Dec 31, 2021 | 176,000.00 |
| Jun 30, 2021 | 241,000.00 |